Gonorrhea is the second most common bacterial sexually transmitted infection in the United States. Rates are increasing, and multiple challenges compound management, including worsening antimicrobial resistance. New therapeutics, enhanced screening and partner notification, and treatment through point-of-care testing and expedited partner therapy, as well as primary prevention efforts provide opportunities for success in combating these trends.
Keywords: Antimicrobial resistance; Expedited partner therapy; Gonorrhea; Point-of-care testing.
Copyright © 2023 Elsevier Inc. All rights reserved.